Hyperion DeFi, Inc. (HYPD)

NASDAQ: HYPD · Real-Time Price · USD
14.36
-1.46 (-9.23%)
At close: Jul 3, 2025, 1:00 PM
14.04
-0.32 (-2.23%)
After-hours: Jul 3, 2025, 4:59 PM EDT
-9.23%
Market Cap 73.30M
Revenue (ttm) 67,063
Net Income (ttm) -42.38M
Shares Out 5.10M
EPS (ttm) -34.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,323,691
Open 16.30
Previous Close 15.82
Day's Range 13.00 - 16.35
52-Week Range 0.85 - 124.80
Beta 2.48
Analysts n/a
Price Target n/a
Earnings Date Aug 8, 2025

About HYPD

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jan 25, 2018
Employees 14
Stock Exchange NASDAQ
Ticker Symbol HYPD
Full Company Profile

Financial Performance

In 2024, Hyperion DeFi's revenue was $57,336, an increase of 1414.02% compared to the previous year's $3,787. Losses were -$49.82 million, 82.7% more than in 2023.

Financial Statements

News

There is no news available yet.